Dengue Virus Antibody (9.F.10): sc-70959
- Dengue Virus Antibody (9.F.10) is a mouse monoclonal IgG2a, cited in 5 publications, provided at 100 µg/ml
- raised against Dengue Virus serotypes 1, 2, 3, and 4
- recommended for detection of Dengue Virus 1, 2, 3 and 4 of Dengue Virus 1, 2, 3 and and 4 origin by WB, IF and IHC(P)
- At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for Dengue Virus Antibody (9.F.10). This work is in progress.
QUICK LINKS
Dengue Virus Antibody (9.F.10) is a mouse monoclonal IgG2a antibody that detects Dengue Virus across serotypes 1, 2, 3, and 4 through western blotting (WB), immunofluorescence (IF), and immunohistochemistry. Anti-Dengue Virus antibody (9.F.10) plays a crucial role in studying Dengue Virus, a member of the Flavivirus genus responsible for causing Dengue fever, a significant public health concern in tropical regions. The virus′s genome consists of a single-stranded positive-sense RNA that encodes three structural proteins—capsid, membrane, and envelope—as well as seven nonstructural proteins essential for viral replication and pathogenesis. The envelope protein facilitates fusion of viral and cellular membranes, enabling viral entry into host cells for replication. Understanding these proteins′ structure and function is vital for developing effective vaccines and therapeutic strategies against Dengue fever, and for elucidating viral infection and immune response mechanisms.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Dengue Virus Antibody (9.F.10) References:
- Neurological complications of dengue virus infection. | Carod-Artal, FJ., et al. 2013. Lancet Neurol. 12: 906-919. PMID: 23948177
- Dengue virus vaccine development. | Yauch, LE. and Shresta, S. 2014. Adv Virus Res. 88: 315-72. PMID: 24373316
- Pharmacological intervention for dengue virus infection. | Lai, JH., et al. 2017. Biochem Pharmacol. 129: 14-25. PMID: 28104437
- New insight on dengue virus-induced thrombocytopenia. | Goldthorpe, SC. and Conway, MJ. 2017. Virulence. 8: 1492-1493. PMID: 28829671
- Discovery of Dengue Virus Inhibitors. | Abdullah, AA., et al. 2020. Curr Med Chem. 27: 4945-5036. PMID: 30514185
- Dengue virus and the complement alternative pathway. | Carr, JM., et al. 2020. FEBS Lett. 594: 2543-2555. PMID: 31943152
- microRNAs, the Link Between Dengue Virus and the Host Genome. | Su, Y., et al. 2021. Front Microbiol. 12: 714409. PMID: 34456895
- Contribution of phylogenetics to understanding the evolution and epidemiology of dengue virus. | Yu, X. and Cheng, G. 2022. Animal Model Exp Med. 5: 410-417. PMID: 36245335
- Host immunity and vaccine development against Dengue virus. | Ma, E. and Cheng, G. 2022. Infect Med (Beijing). 1: 50-58. PMID: 38074980
- Cross Talk between MicroRNAs and Dengue Virus. | Macha, NO., et al. 2024. Am J Trop Med Hyg. 110: 856-867. PMID: 38579704
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Dengue Virus Antibody (9.F.10) | sc-70959 | 100 µg/ml | $322.00 |